If you’ve been following iPhone news, you may have heard rumors that the iPhone 14 and iPhone 14 Max will use the same A15 Bionic chipset as the iPhone 13 series. This seems like an unusual decision for Apple, but now a new voice has emerged as to why this decision could be made.
Mark Gurman, a journalist and leaker with a good track record of Apple information, points out in a Bloomberg newsletter that iPhone chips have had to stay in the background as Apple is currently focusing so much on developing Mac chips.
Gurman points out that Apple has launched five main types of Mac chips in the last 18 months, and claims the company plans at least four more for the next year.
Developing chipsets this fast required a tremendous amount of work, so Apple apparently had to move most of its development resources to these chipsets, which include the M1, M1 Ultra, M2, and others. While Gurman doesn’t explicitly say this has led to Apple using the A15 Bionic two years in a row, he says the focus on the Mac is a big factor and there aren’t enough resources to focus strongly on other chipsets as well.
Focusing on the Mac is probably not the only issue, Gurman adds, as there are other possible factors as well, such as dependency on other companies (most notably TSMC) and rising costs caused by the global chipset shortage.
38721
